Enliven Therapeutics
ELVNInsider trades and stock quote 2022-2024
All insider trades at Enliven Therapeutics
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 10/9/2024 | Sell | Kintz, Samuel | PRESIDENT AND CEO | $28.3 | $470,405 |
| 10/9/2024 | Sell | Lyssikatos, Joseph P. | CHIEF SCIENTIFIC OFFICER | $28.3 | $1,066,561 |
| 10/8/2024 | Sell | Ballal, Rahul D. | Director | $28.2 | $293,557 |
| 10/8/2024 | Sell | Kintz, Samuel | PRESIDENT AND CEO | $28.2 | $370,929 |
| 10/8/2024 | Sell | Lyssikatos, Joseph P. | CHIEF SCIENTIFIC OFFICER | $28.2 | $371,024 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)